Decision Support for Heart Failure Prescribing

Heart Failure Clinical Trial

Official title: New Solutions to Support Evidence-based Prescribing for Heart Failure

Status Not yet recruiting

Clinical Trial Summary

Clinical decision support (CDS) tools can 'nudge' clinicians to make the best decisions easy. Although required by "meaningful use" regulations, more than 40% of CDS lead to no change and the remaining lead to improvements that are modest at best. This is because CDS tools often ignore contextual factors and present irrelevant information. Although many tools have undergone patient-specific optimization, 'traditional CDS' are rarely clinician-specific. For example, a traditional CDS tool for beta blockers and heart failure with reduced ejection fraction (HFrEF) addresses common prescribing misconceptions by stating asthma is not a contraindication and providing a safe threshold for blood pressure. For clinicians without these misconceptions, these statements are irrelevant and distract from key information. A 'personalized CDS' would evaluate clinician past prescribing patterns to determine whether prescribing misconceptions might exist and then conditionally present information to address those misconceptions. The objective of this research is to create personalized clinician-specific CDS that overcome shortcomings of traditional CDS. The central hypothesis is a personalized CDS that minimizes irrelevant information will lead to a higher rate of prescribing guideline-directed management and therapy (GDMT) for HFrEF compared to a traditional CDS.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Decision Support Systems, Clinical
• Heart Failure

• NCT number: NCT06293794
• Study type: Interventional
• Source: University of Colorado, Denver
• Contact: Katy Trinkley, PharmD, PhD
• Phone: (303) 724-3103
• Email: katy.trinkley@cuanschutz.edu
• Status: Not yet recruiting
• Phase: N/A
• Start date: June 2024
• Completion date: September 2025